Trevor Kimbler

Trevor Kimbler has a diverse work experience spanning over 20 years. Trevor started their career as a Research Assistant at the University of Arizona in 2001, where they worked until 2003. Trevor then joined EMD Chemicals as a Research Associate in Research and Development, and stayed with the company until 2007. While at EMD Chemicals, Trevor gained experience in various research techniques.

In 2007, Trevor moved on to the University of California, San Diego - School of Medicine as a Staff Research Associate. During their time there, they conducted scientific studies and translational research focused on autoimmune diseases. Trevor implemented a wide range of techniques, such as flow cytometry, western blot, ELISA, RNA/DNA isolation, and T cell proliferation assays. Trevor's work also involved isolating and culturing human PBMCs and synoviocytes.

From 2011 to 2013, Trevor worked at CalciMedica Inc. as a Senior Research Associate, contributing to research in the pharmaceutical industry. Trevor then joined AnaptysBio in 2014, where they served as a Senior Research Associate for a brief period before transitioning to the Genomics Institute of the Novartis Research Foundation as a Scientific Associate II. Trevor's experience at these companies enhanced their expertise in scientific research.

In 2016, Trevor joined Halozyme Therapeutics, Inc. as a Research Scientist I. Trevor worked there until 2019, gaining further experience in scientific research and development. Following this, Trevor worked at Pfizer as a Scientist from 2019 to 2021, where their contributions significantly impacted the company's scientific advancements.

Most recently, Trevor Kimbler joined Kumquat Biosciences Inc. in 2021 as a Scientist I, further expanding their knowledge and skills in the field.

Trevor Kimbler earned a Bachelor's Degree in Ecology and Evolutionary Biology from the University of Arizona, completing their studies between 1999 and 2004.